Although further investigation is required, TUG1 ASO may be a powerful strategy for targeting this dire tumor entity, particularly because of its synergetic effects with TMZ or Irinotecan, an analog of CPT also clinically used for glioblastoma treatment. Here, TUG1 is linked to glioblastoma.